Related Experiment Videos
Managing the asymptomatic diabetic patient with silent myocardial ischaemia
1Department of Internal Medicine, Cardiology Unit, Stellenbosch University and Tygerberg Hospital, South Africa.
Insights
Diabetic patients with cardiac risk factors benefit from screening for silent myocardial ischemia. Early detection and aggressive risk factor management, including glycemic control and aspirin, are crucial.
Area of Science:
- Cardiology
- Diabetology
- Preventive Medicine
Background:
- Coronary artery disease (CAD) is a leading cause of mortality in diabetic patients.
- Myocardial ischemia in diabetics often presents asymptomatically, complicating diagnosis and management.
- Physicians face challenges in identifying diabetic patients who would benefit from ischemia screening.
Purpose of the Study:
- To determine the benefit of screening for silent myocardial ischemia in diabetic patients.
- To identify subgroups of diabetic patients most likely to benefit from screening.
- To outline appropriate screening and risk stratification strategies.
Main Methods:
- Standard treadmill stress electrocardiogram (ECG) is recommended for screening.
- Additional tests like microalbuminuria and C-reactive protein (CRP) levels aid in high-risk patient selection.
- Risk stratification considers multiple cardiac risk factors (dyslipidemia, hypertension, smoking, family history, microalbuminuria) and established macrovascular disease.
Main Results:
- Diabetic patients with multiple cardiac risk factors or established macrovascular disease show the greatest benefit from screening.
- Microalbuminuria and elevated CRP levels are valuable markers for risk stratification.
- Stress ECG findings and the number of risk factors guide decisions for further intervention.
Conclusions:
- Selective screening for silent myocardial ischemia is recommended for specific diabetic patient subgroups.
- Aggressive management of risk factors, glycemic control, and aspirin therapy are foundational treatments.
- Referral for angiography and potential intervention is considered based on prognostic indicators and risk factor burden.
Abstract:
Coronary artery disease is common in diabetic patients and remains the major cause of death in these patients. However myocardial ischaemia resulting from coronary lesions does not always give rise to symptoms. The managing physician must therefore consider the benefit of screening for silent myocardial ischaemia in diabetic patients. Screening all diabetic patients is not recommended. The challenge to the physician is to select the patient subgroups likely to benefit from screening. Patients with more than one cardiac risk factor (dyslipidaemia, hypertension, smoking, family history, micro-albuminuria) in addition to diabetes, as well as patients with established macrovascular disease, e.g. peripheral vascular disease, will benefit most from screening. A standard treadmill stress ECG is the recommended screening test. A number of additional tests have been proposed to select high-risk patients for screening. Of these, testing for microalbuminuria and elevated CRP levels are most likely to influence decision-making. Once silent ischaemia has been detected in a diabetic patient, the mainstay of treatment remains the aggressive control of risk factors, improvement of glycaemic control and aspirin therapy. The use of beta-blockers and ACE-inhibitors often need consideration. The attending physician must then consider referring the patient to a cardiologist for angiography and possible intervention. This decision is based on the presence of poor prognostic signs during the stress ECG and the number of risk factors present. Microalbuminuria and elevated CRP levels are helpful in assisting with the risk stratification process.